甘草西定通过调节PTPN1活性抑制T细胞活化并改善特应性皮炎
研究从甘草提取物中分离的甘草西定,在体外抑制T细胞IL-2 mRNA表达且无细胞毒性,并通过调控PTPN1活性维持Lck磷酸化;在DNCB和/或螨提取物诱导的小鼠AD模型中,甘草西定减轻耳厚度、血清IgE水平及炎症细胞浸润,提示其治疗AD的潜力。
要点
- 甘草西定无细胞毒性抑制T细胞IL-2 mRNA表达。
- 甘草西定通过调控PTPN1活性维持Lck磷酸化。
- 甘草西定改善AD小鼠耳厚度、血清IgE及炎症。
核心结论
- 甘草西定具有治疗特应性皮炎的潜力,机制涉及通过调控PTPN1活性来有效调节T细胞活化。
研究设计与样本
- 体外实验使用刺激的T细胞,体内实验使用二硝基氯苯(DNCB)和/或螨提取物诱导的AD小鼠模型。
主要发现
- 甘草西定在无细胞毒性下减弱刺激T细胞中IL-2 mRNA的表达。
- 甘草西定预处理控制TCR介导刺激下Lck的去磷酸化。
- 甘草西定减轻DNCB和/或螨提取物诱导的AD小鼠耳厚度和血清IgE水平。
- 显微镜分析显示甘草西定影响AD小鼠真皮和表皮厚度及免疫细胞浸润。
- 甘草西定处理AD小鼠耳病变中促炎细胞因子mRNA水平降低。
临床怎么用
- 甘草西定可能作为治疗特应性皮炎的候选药物,其机制涉及调控PTPN1活性以维持Lck磷酸化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Licoricidin, the fifth-highest fraction among the isolated 48 molecules from Glycyrrhiza uralensis extracts, has been known as an anti-inflammatory bioactive molecule; however, few studies have shown its inhibitory effect on T-cell activation and atopic dermatitis (AD). This study examined the therapeutic potential of licoricidin in AD by modulating T-cell activation with molecular mechanisms. Licoricidin attenuated the expression of IL-2 mRNA in stimulated T cells without cytotoxicity. Because tyrosine-protein phosphatase nonreceptor type 1 was predicted to interact physically with licoricidin in T cells in silico analysis, the results of tyrosine-protein phosphatase nonreceptor type 1 activity assay and phosphorylation study predicted that licoricidin might abrogate the activity of tyrosine-protein phosphatase nonreceptor type 1 during T-cell activation. Pretreatment with licoricidin controlled the dephosphorylation of Lck on TCR-mediated stimulation. Moreover, licoricidin alleviated the symptoms of dinitrochlorobenzene- and/or mite extract-induced AD, including ear thickness and serum IgE level. Microscopic analysis also showed the effects of licoricidin on the thickness of the dermis and epidermis and infiltration of immune cells. Furthermore, mRNA levels of proinflammatory cytokines were attenuated in the ear lesions of licoricidin-treated AD mice. Therefore, licoricidin has therapeutic potential for treating AD, and its underlying mechanism involves effective modulation of T-cell activation by controlling tyrosine-protein phosphatase nonreceptor type 1 to maintain Lck phosphorylation.
引用
- Lee HS, Kim J, Choi HG, et al. Licoricidin Abrogates T-Cell Activation by Modulating PTPN1 Activity and Attenuates Atopic Dermatitis In Vivo. J Invest Dermatol. 2021. PMID: 33857487. doi:10.1016/j.jid.2021.02.759
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。